Try our beta test site
387 studies found for:    Open Studies | "Carcinoma, Hepatocellular"
Show Display Options
Rank Status Study
21 Recruiting 18F-FluoroethylCholine Positron Emission Tomography: a Promising Diagnostic Tool for Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: 18F-FluoroethylCholine PET
22 Recruiting Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: The imaging biomarkers determined by MR-PET
23 Recruiting Pembrolizumab (Keytruda) in Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Drug: Pembrolizumab;   Procedure: Peripheral Blood Sample (optional);   Genetic: Tumor Tissue Collection (optional)
24 Recruiting Study of Apatinib in Advanced Hepatocellular Carcinoma(HCC)
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib
25 Recruiting Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Drug: Sorafenib
26 Recruiting Liver Perfusion MRI With Quantification of Tumoral Perfusion for Early Assessment of the Response of Antiangiogenics Treatments in Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Intervention: Device: liver Perfusion MRI
27 Not yet recruiting Study of the Combination of TACE With Apatinib in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma
Interventions: Procedure: TACE and Apatinib;   Procedure: TACE
28 Recruiting Hepatic Arterial Infusion Chemotherapy(HAIC) for Hepatoma After Resection
Condition: Hepatocellular Carcinoma
Interventions: Drug: Oxaliplatin(OXA), 5-fluorouracil (5-FU);   Procedure: Hepatic arterial catheter implantation
29 Recruiting Phase 2, Randomized, Double-Blind, Placebo-Controlled of the Efficacy and Safety of CF102 in Hepatocellular Carcinoma (HCC)
Condition: Hepatocellular Carcinoma
Interventions: Drug: CF102;   Drug: Placebo
30 Not yet recruiting Glypican 3-specific Chimeric Antigen Receptor Expressing T Cells for Hepatocellular Carcinoma (GLYCAR)
Condition: Hepatocellular Carcinoma
Interventions: Genetic: GLYCAR T cells;   Drug: Cytoxan;   Drug: Fludarabine
31 Not yet recruiting A Study of DC-CIK to Treat Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma (HCC)
Intervention: Biological: Dendritic and Cytokine-induced Killer Cells
32 Recruiting RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma, Adult
Interventions: Drug: Chemotherapy drug;   Drug: Embolic agents;   Procedure: Simultaneously;   Procedure: Sequentially;   Device: Ablation
33 Recruiting Observational Prospective Study on Chemoembolization With Doxorubicin for Unresectable Hepatocellular Carcinoma
Condition: Liver Cell Carcinoma Non-resectable
Intervention:
34 Recruiting 188RE-SSS Lipiodol to Treat HepatoCellular Carcinomas
Condition: Hepatocellular Carcinomas
Intervention: Drug: 188Re-SSS Lipiodol
35 Not yet recruiting Dynamic Contrast Enhanced HCC SABR Liver Study
Condition: Carcinoma, Hepatocellular
Intervention: Procedure: Perfusion Imaging
36 Recruiting Transarterial Chemoembolization (TACE) Plus Sorafenib Versus TACE for Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Interventions: Procedure: TACE+Sorafenib;   Procedure: TACE
37 Recruiting Treatment for Patients With Multiple Hepatocellular Carcinomas Based on the NDR Scoring System
Condition: Hepatocellular Carcinoma
Interventions: Procedure: Hepatectomy;   Procedure: TACE
38 Recruiting Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Subjects With Advanced Hepatocellular Carcinoma
Condition: Advanced Hepatocellular Carcinoma
Intervention: Drug: H3B-6527
39 Recruiting A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellular Carcinoma (HCC)
Condition: Carcinoma, Hepatocellular
Interventions: Drug: CC-122;   Drug: Nivolumab
40 Recruiting TCR-Redirected T Cell Infusions to Prevent Hepatocellular Carcinoma Recurrence Post Liver Transplantation
Condition: Hepatocellular Carcinoma
Intervention: Other: Biological: HBV antigen specific TCR redirected T cell

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.